| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5599372 | Atherosclerosis | 2017 | 33 Pages |
Abstract
Long-term treatment with anacetrapib 100Â mg substantially reduced LDL-C, increased HDL-C and was well tolerated in Japanese patients with dyslipidemia (ClinicalTrials.gov number NCT01760460).
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tamio Teramoto, Hiroyuki Daida, Katsunori Ikewaki, Hidenori Arai, Yuko Maeda, Mariko Nakagomi, Masayoshi Shirakawa, Yuichiro Watanabe, Taro Kakikawa, Hirotaka Numaguchi, Amy O. Johnson-Levonas, Robert O. Blaustein,